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The purpose of this study was to determine an effective dosage for constraint-induced 
movement therapy (CIMT) in pediatric patients with hemiplegic cerebral palsy (CP). This 
objective was achieved by randomly assigning subjects to either the high-dosage treatment group 
(6 hours/day) or the moderate-dosage treatment group (3 hours/day). The hypothesized outcome 
was that subjects in the high-dosage group would see greater improvements in functional upper 
arm movements following the 21 days of CIMT, including long-arm casting.  Participants were 
assigned to one of three research sites where they underwent their therapy and were evaluated on 
baseline and progress via outcome measures 1- week prior, and 1-week and 1-month following 
treatment. The selected outcome measures were the Assisting Hand Assessment (AHA), the 
Quality of Upper Extremity Skills Test (QUEST), the Shriners Hospital Upper Extremity 
Evaluation (SHUEE) and the Pediatric Motor Activity Log (PMAL). Blinded physical and 
occupational therapists performed the evaluations while therapist involved in the treatment 
interventions had pediatric experience and underwent a training in the CIMT protocol used. 
There were 18 total participants, there was no subject attrition, and all participants completed all 
aspects of the treatment plan.  
The study found that both dosage groups demonstrated significant improvements on each 
outcome measure however, there were no significant differences dependent on dosage group. It 
was concluded that both high-dosage and moderate-dosage CIMT for treatment of pediatric 
patients with hemiplegic cerebral palsy were effective for improvements in functional upper arm 
movements. These results were not in concordance with the hypothesis but are clinically 
relevant. The authors suggested that future studies strive to evaluate the effects of alternative 
 
 
CIMT administration methods, more individualized CIMT programs and varied casting 
approaches including duration and technique. 
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Introduction 
Constraint-induced movement therapy (CIMT) is a therapy form meant to improve 
functional abilities of the upper extremities with emphasis on forced use of the affected limb. 
This therapy type is frequently used for patients who have suffered from central nervous system 
(CNS) injury. Improved use of the affected limb is usually accomplished by restraint of the non-
affected limb. I became acquainted with CIMT as a potential treatment for cerebral palsy (CP) 
during my observational experiences at a pediatric clinic. At the time I observed this treatment I 
was unaware of the technique but was fascinated by the progress in functionality that the child 
was making. Following formal introduction to CIMT in motor control I was curious to further 
assess the effectiveness of CIMT as a treatment option. The research question backing this 
clinical appraisal reads: Is constraint- induced movement therapy (CIMT) an effective treatment 
option for improving the functional independence of pediatric patients with Cerebral Palsy? 
 
Methods 
 The literature search began in PubMed. Two articles pertaining to the research question 
were found, however the PubMed search became limited due to availability of full text articles. 
The search continued using the ASU Academic Search Complete database and one additional 
article was found. The keywords used in the search were CIMT, pediatric and cerebral palsy. The 
 
 
PubMed database search was filtered by “Randomized controlled trial” and “clinical trial.” 
Though these filters limited the search, it was appropriate to guarantee meeting the criteria for 
the assignment. The ASU Academic Search Complete database search was filtered by “full text” 
given repeated encounters with abstracts requiring purchase for the complete text. The inclusions 
criteria for this search were population and interventions. The population inclusions were 
pediatric patients with CP, while intervention criteria was the use of CIMT. Using the keywords 
in the PubMed database, the total number of hits was 42 articles. This is a significant number 
given the rather specific search, however many of these hits were either systematic reviews or 
full text articles for purchase.  
The article for critical appraisal was published in 2012 in the Journal of Pediatric 
Rehabilitation Medicine: An Interdisciplinary Approach. The corresponding author, Stephanie 
DeLuca, appeared several times in the initial search for research articles on CIMT in pediatric 
populations with CP. This was a multisite study that took place at the Ohio State University, the 
University of Virginia, the University of Alabama at Birmingham, and randomization of 
participants occurred at Georgetown University. Despite a small sample size of participants, the 
study involved random allocation of participants to groups and masked therapists to the patients’ 
group status. Therapists were monitored for treatment fidelity and were required to fill out a 
daily log of activities. All participants had a similar clinical background in that their unilateral 
CP was a result of CNS lesion before the age of one month and had never received CIMT. There 
was no participant attrition. Lastly, the selected methods of upper extremity assessment of 
functionality (AHA, SHUEE, QUEST) were evaluated for reliability and exhibited high intra-





Summary of the study 
Constraint- Induced Movement Therapy (CIMT) is a therapeutic technique emphasizing 
daily high intensity and long duration therapy with constraint of the non-affected limb to 
promote increased functionality in the affected limb. This randomized controlled trial (RCT) 
strove to compare the effectiveness of varying dosage CIMT for pediatric patients with cerebral 
palsy (CP). Eighteen children between the ages of 3 and 6, all with unilateral CP, were randomly 
assigned to either the high dosage (6 hours/day) or the moderate dosage (3 hours/day) groups. 
All participants had their non-affected arms casted for the duration of the 21-day study and 
underwent a series of baseline testing of upper extremity functionality (AHA, SHUEE, QUEST), 
including a parental assessment of abilities (PMAL). The study found there were no significant 
differences in improvements between high and moderate dosage CIMT and that participants in 
both groups demonstrated improvements in upper extremity functionality following the treatment 
intervention.  
Appraisal of the study introduction 
The introduction was overall well written and informative. The authors presented a strong 
explanation of CIMT and used scientific literature to support the use of CIMT in young populations with 
CP. The intent of the study was justified by acknowledging the recommendations of prior scientific 
literature on the subject.  
The only potential weakness of the introduction would be the inclusion of older works in the 
literature review. The literature published earlier than 20 years ago (reference 20 and 21) was the initial 
manual published for QUEST (an outcome measure) and an assessment of its reliability. Reference 10 
was published over 30 years ago but served to provide historical context of CIMT developed for 
 
 
rehabilitating stroke patients.  While these sources cannot be considered current, they did serve the 
introduction in an effective manner. 
Appraisal of the study methods 
This study was a longitudinal and prospective RCT in which treatment assessors were blinded to 
patients’ treatment group. The study adhered to inclusion and exclusion criteria as 92 children were 
assessed for eligibility and only 18 children between the ages of 3 and 6 with unilateral CP were 
recruited and participated. Subjects were randomly assigned to their treatment group following 
enrollment using the Data Coordinating and Analysis Center (DCAC) for randomization of group 
assignment. The two treatment groups did have similar clinical characteristics in that all participants 
shared a diagnosis of unilateral CP because of CNS lesions occurring prior to turning one month old. 
Treatments were consistent as all groups were managed the same except for the quantity of experimental 
intervention. Additionally, the therapists implementing the interventions adhered to the ACQUIRE 
CIMT protocol.  
 The intervention was described thoroughly and clearly except for specific exercises included in 
the ACQUIRE CIMT protocol. The process was detailed when discussing casting, location of 
interventions and therapist responses but was vague when discussing specific activities that the child 
was doing. Replicability of the specific activities would be difficult. Another weakness of this study is 
that it was not explicitly stated whether the therapists performing the interventions were blinded to the 
participant treatment group. Despite being carefully monitored for consistency and adherence to the 
protocol, this could prove to be bias in treatment implementation.  
Appraisal of the study results 
 
 
 The study had no subject attrition and results were obtained using outcome measures that 
were assessed for inter- and intra-rater reliability. The results addressed the research question and 
disproved the hypothesis that a higher dosage of CIMT would produce significantly greater 
improvements in upper extremity functionality. The results were clinically meaningful because 
they demonstrated both high and moderate doses of CIMT as an effective treatment that 
promotes flexibility to accommodate the schedule of the patient and their family. 
The figures and tables presented in the results section exhibited formatting issues and title 
inconsistencies when representing data from a single outcome measure (SHUEE). The axes in 
Figure 2 were covered by the data making legibility difficult. Additionally, the methods section 
acknowledges the conversion of raw data to Logit scores, but the meanings of Logit scores are 
not clear. Lastly, each of the figure names show the complete name of each outcome measure. 
Prior to this point, the outcome measures are only referred to as acronyms. This is confusing and 
the authors should have remained consistent with their use of the acronym or stated the full name 
of the test at some point prior to the results.   
Appraisal of the study discussion 
 The authors did further indicate their findings and elaborate on the implications of their 
results. The results were tied back to the existing literature supporting CIMT as an effective 
treatment for CP by providing information on dosage. Limitations of the study were 
acknowledged, and suggestions were provided for future studies to determine the minimum 
threshold of improvement, use of larger sample sizes and investigation into specific 
characteristics in children and how these impact the benefits of CIMT.  
 Clinical significance of the study was not addressed. The authors did speculate that 
insufficient participant attention or 3 hours/day being the maximum benefit one can receive from 
 
 
CIMT could be potential reasons for more CIMT not equating to greater rehabilitation benefits. 
While these speculations are relevant, they are not a discussion of clinical significance.   
 
Discussion 
This study provides an important consideration for PTs working with pediatric patients 
with CP. If improving functionality is a therapeutic goal, then CIMT should be a consideration 
for the plan of care. The results directly pertain to my research question and provide information 
regarding the dosage of CIMT.  Considering both high and moderate dosage CIMT is beneficial 
in improving functionality, therapists have flexibility in designing therapy plans that best meet 
the availability and lifestyle of their patients.  
 The intervention selected for this method was effective and demonstrated clinically 
significant improvements in functional abilities of the upper extremities. The risks of CIMT and 
the involved casting were relatively low, and participants were evaluated for skin integrity 
weekly. Subjects exhibited no major discomforts with the casting and there was no subject 
attrition to suggest issues with the intervention. The potential benefits of increased functionality 
do outweigh the potential risks of using CIMT. Future studies should evaluate what the 
minimum amount of CIMT is to see similar benefits because at least 3 hours/day of therapy may 
not always be feasible.   
 The evidence supporting CIMT as an effective method in this article and previous 
literature is an important consideration for physical therapists. Confidence in this treatment can 
be attributed to the reliable outcome measures used to acquire these results and CIMT should be 
considered beneficial for improving upper extremity function in pediatric patients with CP. 
 
 
Given the intensity of this treatment, effective outcomes in practice would require commitment 
from the therapist, the patient, and their family to maximize improvements and safety.  
 CIMT is established as an effective intervention for pediatric patients with CP and this 
study contributed to the field’s knowledge by providing insight into effective dosage. While 
more research is needed to fine-tune CIMT dosage information, this study contributed 
momentum to the pursuit. Overall, the authors present a comprehensive case for the use of CIMT 
in pediatric patients with CP.   
  
